Virtus LifeSci Biotech Clinical Trials ETF (BBC)

Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund in the Health category. It has $50.32M in assets, an expense ratio of 0.65% and a 1.24% dividend yield. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.